Bernard L. Marini

1.7k total citations
89 papers, 914 citations indexed

About

Bernard L. Marini is a scholar working on Oncology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bernard L. Marini has authored 89 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 37 papers in Hematology and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bernard L. Marini's work include Acute Myeloid Leukemia Research (25 papers), Acute Lymphoblastic Leukemia research (22 papers) and Neutropenia and Cancer Infections (17 papers). Bernard L. Marini is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Acute Lymphoblastic Leukemia research (22 papers) and Neutropenia and Cancer Infections (17 papers). Bernard L. Marini collaborates with scholars based in United States, Italy and United Kingdom. Bernard L. Marini's co-authors include Anthony J. Perissinotti, Dale L. Bixby, Patrick W. Burke, Jerod Nagel, Lydia L. Benitez, Bruce Bostrom, Julia Brown, Yoav H. Messinger, Kristen Pettit and Wanda L. Salzer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Bernard L. Marini

81 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard L. Marini United States 18 230 190 187 186 163 89 914
José Luís Poveda Spain 18 199 0.9× 181 1.0× 159 0.9× 160 0.9× 79 0.5× 90 922
Jean‐Marie Leclerc Canada 18 320 1.4× 167 0.9× 231 1.2× 139 0.7× 135 0.8× 57 1.1k
Adam Gassas Canada 19 238 1.0× 124 0.7× 235 1.3× 460 2.5× 214 1.3× 84 1.1k
Dominique Challine France 18 249 1.1× 103 0.5× 126 0.7× 344 1.8× 267 1.6× 34 1.1k
Lutz Renders Germany 22 188 0.8× 204 1.1× 136 0.7× 113 0.6× 200 1.2× 94 1.5k
Saveria Capria Italy 19 442 1.9× 203 1.1× 183 1.0× 543 2.9× 278 1.7× 70 1.3k
Rajat Kumar Canada 20 324 1.4× 202 1.1× 245 1.3× 793 4.3× 148 0.9× 182 1.4k
Christophe Mariat France 20 132 0.6× 130 0.7× 79 0.4× 180 1.0× 118 0.7× 56 1.1k
Richard J. Creger United States 19 281 1.2× 115 0.6× 94 0.5× 470 2.5× 162 1.0× 60 986
Robert B. Geller United States 20 364 1.6× 193 1.0× 232 1.2× 771 4.1× 157 1.0× 48 1.3k

Countries citing papers authored by Bernard L. Marini

Since Specialization
Citations

This map shows the geographic impact of Bernard L. Marini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard L. Marini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard L. Marini more than expected).

Fields of papers citing papers by Bernard L. Marini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard L. Marini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard L. Marini. The network helps show where Bernard L. Marini may publish in the future.

Co-authorship network of co-authors of Bernard L. Marini

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard L. Marini. A scholar is included among the top collaborators of Bernard L. Marini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard L. Marini. Bernard L. Marini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benitez, Lydia L., et al.. (2025). It’s “Blin” a Long Time Coming: The Rise of Blinatumomab in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 25(12). e1086–e1097.
2.
Sun, Duxin, Christian Macedonia, Zhigang Chen, et al.. (2024). Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?. Journal of Medicinal Chemistry. 67(18). 16035–16055. 3 indexed citations
3.
Perissinotti, Anthony J., Bernard L. Marini, Kristen Pettit, et al.. (2023). Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring. Annals of Hematology. 102(11). 3133–3141. 3 indexed citations
4.
Burke, Patrick W., Lydia L. Benitez, Anthony J. Perissinotti, et al.. (2023). Real‐world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan. European Journal Of Haematology. 112(3). 424–432.
5.
Marini, Bernard L., Anthony J. Perissinotti, Kristen Pettit, et al.. (2022). Oncology stewardship in acute myeloid leukemia. Annals of Hematology. 101(8). 1627–1644. 6 indexed citations
6.
7.
Patel, Twisha S, Anthony J. Perissinotti, Lindsay A Petty, et al.. (2021). Utility of methicillin‐resistant Staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML). Transplant Infectious Disease. 23(4). e13612–e13612. 6 indexed citations
8.
Vincent, T., Lydia L. Benitez, Anthony J. Perissinotti, et al.. (2021). Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform. Cancer Genetics. 258-259. 57–60. 4 indexed citations
9.
Benitez, Lydia L., et al.. (2020). Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 21(5). 295–308. 2 indexed citations
10.
Wierzbicki, Kyle, Karthik Ravi, Andrea Franson, et al.. (2020). Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma. Current Oncology Reports. 22(2). 19–19. 41 indexed citations
11.
12.
Perissinotti, Anthony J., Victoria Nachar, Dale L. Bixby, et al.. (2018). The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia. Leukemia Research. 70. 91–96. 18 indexed citations
13.
Linzey, Joseph R., Bernard L. Marini, Amy L. Pasternak, et al.. (2017). Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology. Journal of Neuro-Oncology. 137(1). 155–169. 10 indexed citations
14.
Tang, Laura, Bernard L. Marini, Lydia L. Benitez, et al.. (2017). Risk factors for subtherapeutic levels of posaconazole tablet. Journal of Antimicrobial Chemotherapy. 72(10). 2902–2905. 38 indexed citations
15.
Perissinotti, Anthony J., et al.. (2017). Risk factors and impact of Clostridium difficile recurrence on haematology patients. Journal of Antimicrobial Chemotherapy. 72(5). 1488–1495. 32 indexed citations
16.
17.
Marini, Bernard L., et al.. (2016). Impact of antibacterial prophylaxis during reinduction chemotherapy for relapse/refractory acute myeloid leukemia. Supportive Care in Cancer. 25(2). 541–547. 7 indexed citations
18.
Marini, Bernard L., et al.. (2015). Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia. Supportive Care in Cancer. 23(8). 2287–2295. 13 indexed citations
19.
Marini, Bernard L., et al.. (2014). The effects of an informational video on patient knowledge, satisfaction and compliance with venous thromboembolism prophylaxis: A pilot study. Patient Education and Counseling. 96(2). 264–267. 33 indexed citations
20.
Faust, Susan M., Guanyi Lu, Bernard L. Marini, et al.. (2009). Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection. The Journal of Immunology. 183(11). 7297–7306. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Luís Poveda Breakdown of academic impact, for papers by Jean‐Marie Leclerc Breakdown of academic impact, for papers by Adam Gassas Breakdown of academic impact, for papers by Dominique Challine Breakdown of academic impact, for papers by Lutz Renders Breakdown of academic impact, for papers by Saveria Capria Breakdown of academic impact, for papers by Rajat Kumar Breakdown of academic impact, for papers by Christophe Mariat Breakdown of academic impact, for papers by Richard J. Creger Breakdown of academic impact, for papers by Robert B. Geller
Rankless by CCL
2026